MEET THE PROFESSOR - 6th Advanced Course on Breast Cancer, Modena, September 15th-17th 2010

Wednesday, September 15th

• Introduction

9.30 AM	Lecture 1 Biology of BRCA associated breast cancer Generoso Bevilacqua
10.00 AM	Lecture 2 Hereditary breast cancer not related to BRCA ½ Maria Adelaide Caligo
10.30 AM	Discussion and coffee
11.00 AM	Round Table  Management of BRCA healthy carriers Chair: Massimo Federico Surveillance - Pierosandro Tagliaferri Surgery - Manuela Roncella Chemoprevention - Andrea De Censi
12.00 PM	Lecture 3 The familial breast cancer clinic Massimo Federico
12.30 PM	From technology advances to patient care – 1 Lecture 4 Gene profiling: role in clinical trial design and patient management  Lajos Pusztai
13.15 PM	Lunch
14.15 PM	From technology advances to patient care – 2 Chair: Pietro Torricelli Controversy 1- MRI the good - Christiane Kuhl MRI the bad - Monica Morrow
15.15 PM	Lecture 5 PET- Scan for staging and monitoring Norbert Avril
15.45 PM	Discussion and Coffee
16.15 PM	Lecture 6 Primary systemic therapy for operable breast cancer: from drug development to clinical practice  Luca Gianni
16.45 PM	Clinical case discussions 1: Genetic counselling and screening Laura Cortesi Management of ADH and DCIS Maria Grazia Lazzaretti Molecular subtypes and gene expression profiles Lucia Del Mastro
17.15 PM	Reports of Clinical Cases and open discussion Gianni Tazzioli, Antonio Maiorana
18.00 PM	Adjourn

 

Thursday, September 16th

8.30 AM	Lecture 7 How many breast cancers subtypes for clinicians?  Giuseppe Viale
9.00 AM	Controversy 2- Accelerated Partial breast irradiation: is it ready as a standard treatment approach Yes/ No  Roberto Orecchia, Silvia Formenti
10.00 AM	Lecture 8  Does breast cancer subtype influence locoregional treatments? Eleuterios Mamounas
10.30 AM	Discussion and Coffee
11.00 AM	Lecture 9 Adjuvant treatment of EBC 2010 Gabriel N. Hortobagyi
11.45 AM	Lecture 10 Adjuvant chemotherapy for node negative patients: translating scientific evidence into daily practice Miguel Martin
12.15 PM	Lecture 11 HER2+ EBC: unanswered questions Pier Franco Conte
12.45 PM	Lecture 12 TN disease: from biology to treatment  Ana Maria Gonzalez-Angulo
13.15 PM	Lunch
14.15 PM	Clinical case discussions 2 Sentinel node biopsy and primary systemic therapy  Eleuterios Mamounas Adjuvant treatment of T1N0 Her2+ tumors  Fabio Puglisi HR+ EBC: criteria to prescribe chemotherapy Anna Maria Molino
15.00 PM	Reports of Clinical Cases and open discussion Alberto Bottini, Paolo Pronzato
15.30 PM	Coffee break
16.00 PM	Lecture 13 Inflammatory breast cancer Hussein Khaled
16.30 PM	Lecture 14  Breast cancer stem cells Maria Grazia Daidone
17.00 PM	Ceremony for the presentation of the UniMore Award and the Monica Boscolo Research Grant
17.15 PM	Lecture of the UniMore awardee
17.45 PM	Adjourn

 

Friday, September 17th

8.30 AM	Lecture 15 HR+ disease: from cross-talk to overcome endocrine resistance Stephen Johnston
9.00 AM	Lecture 16 Breast cancer and the bone Antonio Frassoldati
9.20 AM	Lecture 17 Parp Inhibition: from synthetic lethality to a new standard for triple negative tumors Stephen Johnston
9.40 AM	Lecture 18 HER2+ breast cancer: new options, new challenges  Valentina Guarneri
10.00 AM	Coffee break
10.30 AM	Clinical case discussions 3 Multidisciplinary management of CNS metastases Claudio Zamagni Multidisciplinary management of oligometastastic disease Carmelo Bengala Multidisciplinary management of bone metastases Roberto Sabbatini
11.10 AM	Reports of Clinical Cases and open discussion  Ana Maria Gonzalez-Angulo, Christoph Zielienski
11.40 AM	Expert Panel Discussion: Inhibition of angiogenesis: who and when  Chair: David Khayat Participants: Pier Franco Conte, Gabriel N. Hortobagyi, Fikri Icli, Hussein Khaled, Sibylle Loibl, Miguel Martin, Stephen Johnston, Christoph Zielienski
12.30 PM	Lecture 19 Emerging therapeutic targets in breast cancer  Suzette Delaloge
13.00 PM	Adjourn and final evaluation questionnaire

• Risultati Televoto

  • Claudio Zamagni

Website by ISN Virtual Worlds